Beta blockers and alpha2 agonists for cardioprotection

Best Practice and Research: Clinical Anaesthesiology

Volumn 22, Issue 1, 2008, Pages 95-110

  London, Martin J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

alpha2 agonists; beta adrenergic receptor antagonists; perioperative myocardial infarction; risk stratification; surgical outcomes; vascular surgery

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CELIPROLOL; CLONIDINE; DEXMEDETOMIDINE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; ESMOLOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; NEBIVOLOL; NICARDIPINE; PLACEBO; PROPRANOLOL;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DRUG DOSE TITRATION; DRUG INDICATION; HEART INFARCTION; HEART PROTECTION; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; LONG TERM CARE; MORBIDITY; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SAFETY; STRESS; SYMPATHETIC TONE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; CARDIOTONIC AGENTS; CORONARY DISEASE; HUMANS; INTRAOPERATIVE COMPLICATIONS; META-ANALYSIS AS TOPIC; MYOCARDIAL INFARCTION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 41049116669     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2007.09.008     Document Type: Review

References (55)

1. Pasternack P.F., Imparato A.M., Baumann F.G., et al. The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair. Circulation 76 (1987) III1-III7
2. Mangano D.T., Layug E.L., Wallace A., and Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. New England Journal of Medicine 335 (1996) 1713-1720
3. Devereaux P.J., Goldman L., Yusuf S., et al. Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. Canadian Medical Association Journal 173 (2005) 779-788
4. Poldermans D., Boersma E., Bax J.J., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. New England Journal of Medicine 341 (1999) 1789-1794
5. Poldermans D., Boersma E., Bax J.J., et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. European Heart Journal 22 (2001) 1353-1358
6. Dorman B.H., Zucker J.R., Verrier E.D., et al. Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirement, and alters hemodynamic parameters in patients undergoing coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia 7 (1993) 386-395
7. Anon. Perioperative sympatholysis. Beneficial effects of the alpha 2-adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. McSPI - Europe Research Group. Anesthesiology 86 (1997) 346-363
8. Oliver M.F., Goldman L., Julian D.G., and Holme I. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology 91 (1999) 951-961
9. Wallace A.W., Galindez D., Salahieh A., et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 101 (2004) 284-293
10. London M.J., Zaugg M., Schaub M.C., and Spahn D.R. Perioperative beta-adrenergic receptor blockade: physiologic foundations and clinical controversies. Anesthesiology 100 (2004) 170-175
11. Devereaux P.J., Yang H., Guyatt G.H., et al. Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. American Heart Journal 152 (2006) 223-230
12. London M.J., Zaugg M., Schaub M.C., and Spahn D.R. A large trial is vital to prove perioperative beta-blockade effectiveness and safety before widespread use. Anesthesiology 101 (2004) 804-805
13. London M.J., Itani K.M., Perrino Jr. A.C., et al. Perioperative beta-blockade: a survey of physician attitudes in the Department of Veterans Affairs. Journal of Cardiothoracic and Vascular Anesthesia 18 (2004) 14-24
14. Nishina K., Mikawa K., Uesugi T., et al. Efficacy of clonidine for prevention of perioperative myocardial ischemia: a critical appraisal and meta-analysis of the literature. Anesthesiology 96 (2002) 323-329
15. Stevens R.D., Burri H., and Tramer M.R. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesthesia and Analgesia 97 (2003) 623-633
16. Wijeysundera D.N., Naik J.S., and Beattie W.S. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. American Journal of Medicine 114 (2003) 742-752
17. Devereaux P.J., Beattie W.S., Choi P.T., et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ (Clinical Research ed.) 331 (2005) 313-321
18. McGory M.L., Maggard M.A., and Ko C.Y. A meta-analysis of perioperative beta blockade: what is the actual risk reduction?. Surgery 138 (2005) 171-179
19. Kapoor A.S., Kanji H., Buckingham J., et al. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ (Clinical Research ed.) 333 (2006) 1149
20. Schouten O., Shaw L.J., Boersma E., et al. A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery. Coronary Artery Disease 17 (2006) 173-179
21. Wiesbauer F., Schlager O., Domanovits H., et al. Perioperative {beta}-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesthesia and Analgesia 104 (2007) 27-41
22. Merin R.G. Anesthetic management problems posed by therapeutic advances: 3. Beta-adrenergic blocking drugs. Anesthesia and Analgesia 51 (1972) 617-624
23. Lindenauer P.K., Pekow P., Wang K., et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. New England Journal of Medicine 353 (2005) 349-361
24. Redelmeier D., Scales D., and Kopp A. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ (Clinical Research ed.) 331 (2005) 932
25. Rinfret S., Abrahamowicz M., Tu J., et al. A population-based analysis of the class effect of beta-blockers after myocardial infarction. American Heart Journal 153 (2007) 224-230
26. Siegel D., Lopez J., and Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. American Journal of Medicine 120 (2007) 26-32
27. Gress T.W., Nieto F.J., Shahar E., et al. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. New England Journal of Medicine 342 (2000) 905-912
28. Chen Z.M., Pan H.C., Chen Y.P., et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1622-1632
29. McEniery C.M., Schmitt M., Qasem A., et al. Nebivolol increases arterial distensibility in vivo. Hypertension 44 (2004) 305-310
30. van der Woude H.J., Zaagsma J., Postma D.S., et al. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers. Chest 127 (2005) 818-824
31. Kindermann M., Maack C., Schaller S., et al. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo. Circulation 109 (2004) 3182-3190
32. Mulder P., Barbier S., Chagraoui A., et al. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 109 (2004) 1674-1679
33. Boudoulas H., Lewis R.P., Rittgers S.E., et al. Increased diastolic time: a possible important factor in the benefical effect of propranolol in patients with coronary artery disease. Journal of Cardiovascular Pharmacology 1 (1979) 503-513
34. Boudoulas H., Rittgers S.E., Lewis R.P., et al. Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion. Circulation 60 (1979) 164-169
35. Heidland U.E., and Strauer B.E. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 104 (2001) 1477-1482
36. Feldman C.L., and Stone P.H. Intravascular hemodynamic factors responsible for progression of coronary atherosclerosis and development of vulnerable plaque. Current Opinion in Cardiology 15 (2000) 430-440
37. Gertz S.D., and Roberts W.C. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. American Journal of Cardiology 66 (1990) 1368-1372
38. Cheng G.C., Loree H.M., Kamm R.D., et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation 87 (1993) 1179-1187
39. Hutcheson I.R., and Griffith T.M. Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow. The American Journal of Physiology 261 (1991) H257-H262
40. Shechter M., Matetzky S., Feinberg M.S., et al. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. Journal of the American College of Cardiology 42 (2003) 2090-2095
41. Balcells M., Fernandez Suarez M., Vazquez M., and Edelman E.R. Cells in fluidic environments are sensitive to flow frequency. Journal of Cellular Physiology 204 (2005) 329-335
42. Hambrecht R., Wolf A., Gielen S., et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. New England Journal of Medicine 342 (2000) 454-460
43. Williams M.J., Low C.J., Wilkins G.T., and Stewart R.A. Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: implications for the risk of plaque rupture. Heart 84 (2000) 377-382
44. Juul A.B., Wetterslev J., Gluud C., et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332 (2006) 1482
45. Yang H., Raymer K., Butler R., et al. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. American Heart Journal 152 (2006) 983-990
46. Brady A.R., Gibbs J.S., Greenhalgh R.M., et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. Journal of Vascular Surgery 41 (2005) 602-609
47. Zaugg M., Bestmann L., Wacker J., et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block. The Swiss Beta Blocker in Spinal Anesthesia (BBSA) Study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 107 (2007) 33-44
48. Feringa H.H., Bax J.J., Boersma E., et al. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation 114 (2006) I344-I349
49. Poldermans D., Bax J.J., Schouten O., et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. Journal of the American College of Cardiology 48 (2006) 964-969
50. Khuri S.F., Daley J., Henderson W., et al. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. Journal of the American College of Surgeons 180 (1995) 519-531
51. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2006 Guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesthesia and Analgesia 104 (2007) 15-26
52. Lionel H. Opie. Mechanisms of cardiac contraction and relaxation. Chapter 19 pages 457-489 in Braunwald's heart disease: a textbook of cardiovascular medicine, Seventh Edition, Elsevier Saunders. 2005.
53. London MJ. Quo vadis, perioperative beta blockade? Are you "POISE'd" on the brink?". Anesthesia Analgesia, in press. (editorial)
54. Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the non-cardiac surgical randomized trials. Anesthesia and Analgesia, in press.
55. Biccard B.M., Sear J.W., and Foex P. Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes. British Journal of Anaesthesia 100 (2008) 23-28